Stability of polycationic complexes of an antisense oligonucleotide in rat small intestine homogenates

被引:16
作者
Ferreiroa, MG
Crooke, RM
Tillman, L
Hardee, G
Bodmeier, R
机构
[1] Free Univ Berlin, Coll Pharm, D-12169 Berlin, Germany
[2] Isis Pharmaceut Inc, Carlsbad, CA USA
关键词
antisense oligonucleotide; polycationic carriers; complex; nuclease metabolism; tissue homogenates; capillary gel electrophoresis;
D O I
10.1016/S0939-6411(02)00140-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Presystemic degradation in the gastrointestinal tract is one of the major problems contributing to the poor oral absorption of antisense oligonucleotides. Complexes between the antisense phosphorothioate oligodeoxynucleotide ISIS 2302 and the polycationic carriers protamine sulfate grade X, prolamine chloride grade V, prolamine phosphate grade X, poly-L-lysine hydrobromide (PLL), spermidine phosphate salt, spermine diphosphate salt, and Protasan(TM) G113 and CL113 were formulated in order to increase stability against intestinal nucleolytic degradation. Specific conductivity measurements were carried out to determine the charge ratio of the complex systems. Nuclease stability assays were performed in a rat small intestine homogenate model, which displayed significant exo-and endonuclease activity. Full-length oligonucleotide and metabolites were analyzed by capillary gel electrophoresis with UV detection at 260 nm. Most of the complexes of ISIS 2302 and the polycationic materials, except PLL-based systems, showed a better protection against enzymatic metabolism than free oligonucleotide. Prolamine sulfate and prolamine chloride considerably enhanced the nuclease stability of the phosphorothioate antisense oligonucleotide. The association of oligonucleotides with several polycationic substances proved to be an alternative to chemical modification in order to stabilize oligonucleotides in the gastrointestinal tract against nucleolytic degradation. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 36 条
[1]  
Agrawal S, 1998, HANDB EXP PHARM, V131, P525
[2]   Association and dissociation characteristics of polymer/DNA complexes used for gene delivery [J].
Arigita, C ;
Zuidam, NJ ;
Crommelin, DJA ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1534-1541
[3]  
Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO
[4]  
2-M
[5]   Pharmacokinetics in mice of a [H-3]-labeled phosphorothioate oligonucleotide formulated in the presence and absence of a cationic lipid [J].
Bennett, CF ;
Zuckerman, JE ;
Kornbrust, D ;
Sasmor, H ;
Leeds, JM ;
Crooke, ST .
JOURNAL OF CONTROLLED RELEASE, 1996, 41 (1-2) :121-130
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]  
Cook PD, 1998, HANDB EXP PHARM, V131, P51
[8]  
Crooke RM, 1998, HANDB EXP PHARM, V131, P103
[9]  
Crooke RM, 2000, J PHARMACOL EXP THER, V292, P140
[10]  
Crooke ST, 1996, J PHARMACOL EXP THER, V277, P923